26 May 2013
Keywords: phosphagenics, gets, ok, ph, tpm-02/insulin, study, melbourne
Article | 10 July 2006
Melbourne, Australia-based Phosphagenics says that it received Ethics Committee approval for a Phase I clinical trial of its transdermal
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 July 2006
3 July 2006
24 May 2013
© 2013 thepharmaletter.com